DO-Why? The Story of DOI
The most important psychedelic research tool you’ve never heard of and why the DEA wants to schedule it.
Articles
Hallucinating Long After the Trip is Over: HPPD – Part 2
Potential causes, risks, and ongoing research for Hallucinogen Persisting Perception Disorder (HPPD).
Hallucinating Long After the Trip is Over: HPPD – Part 1
An overview of the symptoms of Hallucinogen Persisting Perception Disorder (HPPD), how it differs from flashbacks, and how common it might be.
Tackling Trauma with Pharmahuasca and DMT
Psychedelics may hold the key to a novel PTSD treatment.
Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
More than half a century since its development, the head-twitch response assay still plays a prominent role in psychedelic research.
MDMA-Assisted Psychotherapy for PTSD: Interviewing Dr. Rachel Yehuda
Dr. Rachel Yehuda shares details about an ongoing clinical trial involving MDMA-assisted psychotherapy to treat post-traumatic stress disorder in veterans.
COMPASS Patent Challenge Targets Crystallography Errors
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Psychedelics and Substance Use Disorder: 4000 BCE to Present Day
The therapeutic uses of psychedelics were discovered over 6,000 years ago, but recent scientific exploration brings them to the mainstream.
Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity
The pace of psychedelic research continued its acceleration during 2021, culminating in several fascinating and groundbreaking studies. As the year comes to a close, Psychedelic Science Review is acknowledging some...
Editor’s Choice Award 2021-Best Study on Psychedelics and Pharmacology
The pace of psychedelic research continued its acceleration during 2021, culminating in several fascinating and groundbreaking studies. As the year comes to a close, Psychedelic Science Review is acknowledging some...